Study of tanshinone IIA tissue distribution in rat by liquid chromatography-tandem mass spectrometry method

Biomedical Chromatography

Volumn 21, Issue 5, 2007, Pages 473-479

  Bi, Hui Chang ^a   Law, Francis C P ^b   Zhong, Guo Ping ^a   Xu, Chen Shu ^a   Pan, Ying ^a   Ding, Liang ^a   Chen, Xiao ^a   Zhao, Li Zi ^a   Xu, Qiong ^a   Huang, Min ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Liquid chromatography tandem mass spectrometry (LC MS MS); Tanshinone IIA; Tissue distribution

Indexed keywords

HISTOLOGY; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; TISSUE; TISSUE ENGINEERING;

LC-MS-MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY (LC/MS/MS); LIQUID-LIQUID EXTRACTION; RAT TISSUE; SINGLE-STEP; TANSHINONE IIA; TANSHINONES; TISSUE DISTRIBUTIONS;

RATS;

ETHER; FAT; FORMIC ACID; LORATADINE; METHANOL; TANSHINONE; TANSHINONE IIA; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DETERMINATION; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG STRUCTURE; DRUG TISSUE LEVEL; ELECTROSPRAY; FLOW RATE; HEART; KIDNEY; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; LUNG; MALE; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; SMALL INTESTINE; SPLEEN; STOMACH; TANDEM MASS SPECTROMETRY; TESTIS; TISSUE DISTRIBUTION; VALIDATION PROCESS;

RATTUS;

EID: 34248523334     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.778     Document Type: Article

References (28)

1. An LK, Bu XZ, Wu HQ, Guo XD, Ma L and Gu LQ. Reaction of tanshinones with biogenic amine metabolites in vitro. Tetrahedrom 2002; 58: 10315.
2. Bi HC, Zhao LZ, Zhong GP, Zhou SF, Li B, Deng Y, Chen X and Huang M. High-throughput determination of carbocysteine in human plasma by liquid chromatography-tandem mass spectrometry method: application to a bioequivalence study of two formulations in healthy volunteers. Rapid Communications in Mass Spectrometry 2006, 20:1153.
3. Bu XZ, Huang ZS, Zhang M, Ma L, Xiao GW and Gu LQ. Synthesis of new 1,1-diniethyl-1,2,3,4,-tetrahydrophenanthrene derivatives. Tetrahedrom Letters 2001; 42: 5753.
4. Cao EH, Liu XQ, Wang JJ and Xu NE. Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Radical Biology and Medicine 1996; 20: 801.
5. Hao H, Wang G, Li P, Li J and Ding Z. Simultaneous quantification of cryptotanshione and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS). Journal of Pharmaceutical Biomedicine and Analysis 2006; 40: 382.
6. Lee SY, Choi DY and Woo ER. Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza bunge. Archives of Pharmaceutical Research 2005; 28: 909.
7. Li J, Wang G, Li P and Hao H. Simultaneous determination of tanshione IIA and cryptotanshinone in rat plasma by liquid chromatography-electrospray ionisation-mass spectrometry. Journal of Chromatography B 2005; 826: 26.
8. Li P, Wang G, Li J, Hao H and Zheng C. Simultaneous determination of tanshione IIA and its three hydroxylated metabolites by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2006a; 20: 815.
9. Li P, Wang G, Li J, Hao H and Zheng C. Identification of tanshinone IIA metabolites in rat liver microsomes by liquid chromatography-tandem mass spectrometry. Journal of Chromatography A 2006b; 1104: 366.
10. Li P, Wang G, Li J, Hao H and Zheng C. Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry. Journal of Mass Spectrometry 2006c; 41: 670.
11. Li X, Wang Q, Zhang L, Xu L and Yin W. HPLC study of tissue distribution of loganin in rats. Biomedical Chromatography 2006; 20: 1087.
12. Lv C, Zhang L, Wang Q, Liu W, Wang C, Jing X and Liu Y. Determination of piceid in rat plasma and tissues by high-performance liquid chromatographic method with UV detection. Biomedical Chromatography 2006; 20: 1260.
13. Ma WY, Yang JS, Gong CC and Liang L. Effect of Danshen composite on hyperlipaemia and blood rheology. Jiefangjun Yaoxue Xuebao 2001; 17: 47.
14. Mallet CR, Lu Z and Mazzeo JR. A study of ion suppression effects in electrospray ionization from mobile phase additives and solid-phase extracts. Rapid Communications in Mass Spectrometry 2004; 18: 49.
15. Mao JM and Gan ZQ. Clinical observation of Danshen composite on cerebral infarction. Jiefangjun Yaoxue Xuebao 2001; 17: 49.
16. Matuszewski BK, Constanzer ML and Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry 2003; 75: 3019.
17. Qiao JP, Hou PL, Li YW and Abliz Z. Determination of tanshione IIA in rat plasma and the pharmacokinetics by RP-HPLC method. Acta Pharmaceutica Sinica 2003; 38: 368.
18. Takahashi K, Ouyang X, Komatsu K, Nakamura N, Hattori M, Baba A and Azuma J. Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultrured neonatal rat cardiac cells. Biochemistry Pharmacology 2002; 64: 745.
19. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang I and Wang W. Potential anticancer activity of tanshinone IIA against human breast cancer. International Journal of Cancer 2005; 116: 799.
20. Wu XY and Guo XL. Clinical observation of the treatment of 60 hyperlipaemia with Fufang Danshen Dripping Pill. Heibei Zhongyi 2000; 22: 671.
21. Xia WJ, Yang M, Fok TF, Li K, Chan WY, Ng PC, Ng HK, Chik KW, Wang CC, Gu GJ, Woo KS and Fung KP. Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage. Pediatric Research 2005; 58: 784.
22. Xue M, Cui Y, Wang HQ, Hu ZY and Zhang B. Reversed-phase liquid chromatographic determination of cryptotanshinoone and its active metabolite in pig plasma. Journal of Pharmaceutical and Biomedical Analysis 1999; 21: 207.
23. Yang LJ, Jeng CJ, Kung HN, Chang CC, Wang AG, Chau GY, Don MJ and Chau YP. Tanshinone IIA isolated from Salvia Miltiorrhiza elicits the cell death of human endothelial cells. Journal of Biomedical Science 2005; 12: 347.
24. Yoon Y, Kim YO, Jeon WK, Park HJ and Sung HJ. Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL6O human premyelocytic leukemia cell line. Journal of Ethnopharmacology 1999; 68: 121.
25. Yuan SL, Wang XJ and Wei YQ. Anticancer effect of tanshinone and its mechanisms. Ai Zheng 2003; 22:1363.
26. Yuan SL, Wang YQ, Wang XJ, Xiao F, Li SF and Zhang J. Growth inhibition and apoptosis induction of tanshinone IIA on human hepatocellular carcinoma cells. World Journal of Gastroenterology 2004; 10: 2024.
27. Zhao BL, hang W, Zhao Y, Hou JW and Xin WJ. Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia - reperfusion injury. Biochemical and Molecular Biology International 1996; 38: 1171.
28. Zhou L, Zuo Z and Chow MSS. Danshen: an overview of its chemistry, pharmacology, phatmacokinetics, and clinical use. Journal of Clinical Pharmacology 2005; 45: 1345.